Skip to main content
CNVS
NASDAQ Trade & Services

Cineverse Seeks Stockholder Nod for Share Issuance That Could Dilute Existing Holders by Over 100%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Media & Entertainment Stocks · Communication
Sentiment info
Negative
Importance info
8
Price
$2.32
Mkt Cap
$55.967M
52W Low
$1.77
52W High
$6.255
52W Position info
31% above low
Off High info
63% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

CNVS sits 31% above its 52-week low of $1.77 on light trading volume (0.3× avg).

Summary

Cineverse's preliminary proxy seeks stockholder approval to issue up to 21.8 million shares for its IndiCue acquisition and convertible notes, representing over 100% potential dilution. Failure to approve would force cash payments that could materially impact the company's financial condition.


Key Events · Corporate Governance and Compliance · CNVS

  • Nasdaq Proposal Seeks Massive Dilution Approval

    Stockholders are asked to approve issuance of up to 21,805,701 shares — consisting of 6.5M Conversion/Warrant Shares, 1.2M Interest Shares, 4.8M Purchase Price Shares, and 9.3M Earnout Shares — exceeding 100% of the 21.3M shares outstanding pre-acquisition.

  • Financial Impact: Dilution or Cash Crunch

    If approved, existing holders face over 100% dilution. If rejected, the company must pay the $9.2M Purchase Price Shares, any earnout, and note obligations in cash, potentially forcing additional financing and straining liquidity given recent net losses and negative cash flow.

  • Risk of Failure to Obtain Approval

    Failure to approve would require cash payments that could materially adversely affect liquidity and financial condition, and the company would bear costs of seeking approval at subsequent meetings.

  • Special Meeting Date Not Yet Set

    The special meeting date and record date are not yet determined; the proxy is preliminary and subject to completion.


Analysis · CNVS · Trade & Services

Cineverse is asking stockholders to approve the issuance of up to 21.8 million shares — more than the 21.3 million shares outstanding before the IndiCue acquisition — to satisfy stock payments for the acquisition and convertible note conversions. If approved, existing holders face massive dilution. If rejected, the company must pay cash for the acquisition earnout and note obligations, which could strain liquidity given its recent net loss and negative cash flow. The vote is a binary event with significant consequences either way.

At the time of this filing, CNVS was trading at $2.32 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $56M. The 52-week trading range was $1.77 to $6.25. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CNVS - Latest Insights

CNVS
Jun 26, 2026, 8:50 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $3.03
Real-time Price: $2.32 info
Change: -$0.710 (-23%) info
Market Cap: $55.967M info
CNVS
Jun 26, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.55
Real-time Price: $2.32 info
Change: -$0.230 (-9%) info
Market Cap: $55.967M info
CNVS
Jun 26, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $2.84
Real-time Price: $2.32 info
Change: -$0.520 (-18%) info
Market Cap: $55.967M info
CNVS
Jun 24, 2026, 8:32 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.84
Real-time Price: $2.32 info
Change: -$0.520 (-18%) info
Market Cap: $55.967M info
CNVS
Jun 08, 2026, 4:46 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $2.51
Real-time Price: $2.32 info
Change: -$0.190 (-8%) info
Market Cap: $55.967M info